Drug Profile
Propofol injectable - Altus Formulation
Alternative Names: PPI-002Latest Information Update: 06 Nov 2021
Price :
$50
*
At a glance
- Originator Altus Formulation Inc
- Class General anaesthetics; Phenols; Small molecules
- Mechanism of Action GABA receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Anaesthesia
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Anaesthesia in Canada (IV, Injection)
- 29 Jul 2016 Early research in Anaesthesia in Canada (IV)